Joseph M. Miller

Insider Reports History

Location
Edmonton
Signature
/s/ Joseph M. Miller
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Joseph M. Miller:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aurinia Pharmaceuticals Inc. Chief Financial Officer Common Stock 589,127 $9,396,575 $15.95 02 Jan 2026 Direct
Aurinia Pharmaceuticals Inc. Chief Financial Officer Employee Stock Option (right to buy) 124,393 28 Feb 2025 Direct
Avalo Therapeutics, Inc. Director Stock Option (Right to Buy) 20,239 31 Mar 2022 Direct

Insider Reports Filed by Joseph M. Miller

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AUPH Aurinia Pharmaceuticals Inc. 02 Jan 2026 2 -$640,568 4 Chief Financial Officer 05 Jan 2026, 16:11
AUPH Aurinia Pharmaceuticals Inc. 28 Feb 2025 5 -$939,612 4 Chief Financial Officer 04 Mar 2025, 20:58
AUPH Aurinia Pharmaceuticals Inc. 06 Mar 2024 1 -$194,942 4 Chief Financial Officer 07 Mar 2024, 16:44
AUPH Aurinia Pharmaceuticals Inc. 20 Feb 2024 1 $0 4 Chief Financial Officer 22 Feb 2024, 16:27
AUPH Aurinia Pharmaceuticals Inc. 02 Mar 2023 1 -$100,074 4/A Chief Financial Officer 22 Feb 2024, 16:17
AUPH Aurinia Pharmaceuticals Inc. 02 Mar 2023 2 -$100,986 4 Chief Financial Officer 06 Mar 2023, 15:29
AVTX Avalo Therapeutics, Inc. 31 Mar 2022 1 $0 4 Director 04 Apr 2022, 18:06
AUPH Aurinia Pharmaceuticals Inc. 02 Mar 2022 4 -$36,751 4 Chief Financial Officer 04 Mar 2022, 15:12
AVTX Avalo Therapeutics, Inc. 31 Dec 2021 1 $0 4 Director 04 Jan 2022, 15:25
AVTX Avalo Therapeutics, Inc. 30 Sep 2021 1 $0 4 Director 04 Oct 2021, 16:42
AVTX Cerecor Inc. 30 Jun 2021 1 $0 4 Director 02 Jul 2021, 16:11
AVTX Cerecor Inc. 15 Jun 2021 1 $0 4 Director 17 Jun 2021, 16:31
AUPH Aurinia Pharmaceuticals Inc. 11 May 2021 1 +$9,740 4 Chief Financial Officer 11 May 2021, 16:53